<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="105" ids="17234">Glucose</z:chebi> lowering should be approached by managing overall cardiovascular risk </plain></SENT>
<SENT sid="1" pm="."><plain>Glycemic goals should be individualized based on duration of <z:mp ids='MP_0002055'>diabetes</z:mp>, preexisting <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e>, age, and life expectancy </plain></SENT>
<SENT sid="2" pm="."><plain>Intensive glycemic control has consistently been shown to produce a substantial benefit for preventing long-term microvascular complications in both type 1 and type 2 <z:hpo ids='HP_0000819'>diabetes mellitus</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Although <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> is the major cause of <z:hpo ids='HP_0011420'>death</z:hpo> in patients with <z:mp ids='MP_0002055'>diabetes</z:mp>, microvascular complications cause substantial morbidity and disability </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, it is apparent that additional strategies on multimodal treatment options are necessary to promote effective management and prevention of <z:e sem="disease" ids="C0271672" disease_type="Disease or Syndrome" abbrv="">diabetic complications</z:e> </plain></SENT>
</text></document>